Recombinant human granulocyte-macrophage colony-stimulating factor and low-dose cytosine-arabinoside in the treatment of patients with myelodysplastic syndromes. A phase II study

K. Hoffken, F. Overkamp, J. Stirbu, Axel F Grothey, M. Flasshove, D. Hoelzer, A. Ganser

Research output: Contribution to journalArticle

13 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)33-37
Number of pages5
JournalOnkologie
Volume13
Issue number1
StatePublished - 1990
Externally publishedYes

Fingerprint

Drug Dose Response Relationship
Growth Substances
Colony-Stimulating Factors
Combined Modality Therapy
Drug Evaluation
Myelodysplastic Syndromes
Cytarabine
Hematopoiesis
Subcutaneous Injections
Granulocyte-Macrophage Colony-Stimulating Factor
Leukocyte Count
Recombinant Proteins
Multicenter Studies
Therapeutics

ASJC Scopus subject areas

  • Oncology

Cite this

Recombinant human granulocyte-macrophage colony-stimulating factor and low-dose cytosine-arabinoside in the treatment of patients with myelodysplastic syndromes. A phase II study. / Hoffken, K.; Overkamp, F.; Stirbu, J.; Grothey, Axel F; Flasshove, M.; Hoelzer, D.; Ganser, A.

In: Onkologie, Vol. 13, No. 1, 1990, p. 33-37.

Research output: Contribution to journalArticle

Hoffken, K. ; Overkamp, F. ; Stirbu, J. ; Grothey, Axel F ; Flasshove, M. ; Hoelzer, D. ; Ganser, A. / Recombinant human granulocyte-macrophage colony-stimulating factor and low-dose cytosine-arabinoside in the treatment of patients with myelodysplastic syndromes. A phase II study. In: Onkologie. 1990 ; Vol. 13, No. 1. pp. 33-37.
@article{2e530b2f0fa9420d949bede2a34966b6,
title = "Recombinant human granulocyte-macrophage colony-stimulating factor and low-dose cytosine-arabinoside in the treatment of patients with myelodysplastic syndromes. A phase II study",
author = "K. Hoffken and F. Overkamp and J. Stirbu and Grothey, {Axel F} and M. Flasshove and D. Hoelzer and A. Ganser",
year = "1990",
language = "English (US)",
volume = "13",
pages = "33--37",
journal = "Oncology Research and Treatment",
issn = "2296-5270",
publisher = "S. Karger AG",
number = "1",

}

TY - JOUR

T1 - Recombinant human granulocyte-macrophage colony-stimulating factor and low-dose cytosine-arabinoside in the treatment of patients with myelodysplastic syndromes. A phase II study

AU - Hoffken, K.

AU - Overkamp, F.

AU - Stirbu, J.

AU - Grothey, Axel F

AU - Flasshove, M.

AU - Hoelzer, D.

AU - Ganser, A.

PY - 1990

Y1 - 1990

UR - http://www.scopus.com/inward/record.url?scp=0025271460&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025271460&partnerID=8YFLogxK

M3 - Article

C2 - 2186322

AN - SCOPUS:0025271460

VL - 13

SP - 33

EP - 37

JO - Oncology Research and Treatment

JF - Oncology Research and Treatment

SN - 2296-5270

IS - 1

ER -